Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, although some were quite busy, thanks to the American Society of Hematology gathering that got under way (you can read about this here, here, here and here). Now, though, the time has come for everyone to pick up the pace and this calls for — you guessed it — a cup of stimulation. Our choice today is pecan pie. Meanwhile, here are some tidbits to help you along. Have a smashing day and please remember to send us secret documents …

Sanofi (SNY) urged the Philippines to lift the suspension of its dengue vaccine, insisting it was safe, but the government accused the firm of “dishonesty,” The Daily Mail tells us. The vaccine and an immunization program vaccine were suspended after Sanofi warned that Dengvaxia could lead to “severe” symptoms for people who had not previously been infected with dengue.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy